Key points are not available for this paper at this time.
A supported IrO2–RuO2@Ru (3 : 1) catalyst exhibits an IrO2-enriched surface and the intrinsic activity is enhanced obviously compared to that of an alloyed Ir3RuO2 catalyst.
Li et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: